| 利用者成果(英) |
|
19844
Tanaka Y, Nakai T, Suzuki A, Kagawa Y, Noritake O, Taki T, Hashimoto H, Sakai T, Shibata Y, Izumi H, Nosaki K, Udagawa H, Zenke Y, Matsumoto S, Yoh K, Miyazaki S, Sakamoto N, Sakashita S, Kojima M, Watanbe R, Tsuboi M, Goto K, Ishii G.
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma
Cancer Immunol Immunother
2023
72(7):2205-2215
PubMed ID: 36862151
DOI: 10.1007/s00262-023-03393-8
|
|
16739
Hori K, Higashida S, Osaki T, Kawano T, Inaba H, Matsuura K, Iwasaki T.
Intracellular delivery and photothermal therapeutic effects of polyhistidine peptide-modified gold nanoparticles
J Biotechnol
2022
354:34-44
PubMed ID: 35724765
DOI: 10.1016/j.jbiotec.2022.06.006
|
|
13332
Hase H, Aoki M, Matsumoto K, Nakai S, Nagata T, Takeda A, Ueda K, Minami K, Kitae K, Jingushi K, Ueda Y, Yamamoto M, Furukawa T, Sato M, Tsujikawa K.
Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer.
Oncol Rep
2021
PubMed ID: 33155667
DOI: 10.3892/or.2020.7839
|
|
14507
Okita Y, Zheng L, Kawanishi K, Miyoshi H, Yanagihara K, Kato M.
Polyvinyl alcohol scaffolds and supplementation support 3D and sphere culturing of human cancer cell lines by reducing apoptosis and promoting cellular proliferation
Genes Cells
2021
26(5):336-343
PubMed ID: 33638919
DOI: 10.1111/gtc.12843
|
|
14789
Chang A, Liu L, Ashby JM, Wu D, Chen Y, O'Neill SS, Huang S, Wang J, Wang G, Cheng D, Tan X, Petty WJ, Pasche BC, Xiang R, Zhang W, Sun P.
Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer
Cancer Res
2021
81(12):3358-3373
PubMed ID: 33853832
DOI: 10.1158/0008-5472.CAN-21-0688
|
|
15848
Okita R, Shimizu K, Nojima Y, Saisho S, Nakata M.
Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad
Thorac Cancer
2021
12(6):775-782
PubMed ID: 33491334
DOI: 10.1111/1759-7714.13847
|
|
16119
Sanoyama I, Sakurai Y, Ichinoe M, Hoshino A, Kesen Y, Kato T, Numata Y, Umezawa A, Jiang SX, Murakumo Y.
Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation
Pathol Int
2021
71(1):15-23
PubMed ID: 33112501
DOI: 10.1111/pin.13040
|
|
16238
Mikac S, Rychłowski M, Dziadosz A, Szabelska-Beresewicz A, Fahraeus R, Hupp T, Sznarkowska A.
Identification of a Stable, Non-Canonically Regulated Nrf2 Form in Lung Cancer Cells
Antioxidants (Basel)
2021
10(5):786
PubMed ID: 34063559
DOI: 10.3390/antiox10050786
|
|
16801
Minegishi K, Dobashi Y, Tsubochi H, Hagiwara K, Ishibashi Y, Nomura S, Nakamura R, Ohmoto Y, Endo S.
TFF-1 Functions to Suppress Multiple Phenotypes Associated with Lung Cancer Progression
Onco Targets Ther
2021
14:4761-4777
PubMed ID: 34531663
DOI: 10.2147/OTT.S322697
|
|
12073
Haruna M, Hirata M, Iwahori K, Kanazawa T, Yamamoto Y, Goto K, Kawashima A, Morimoto-Okazawa A, Funaki S, Shintani Y, Kumanogoh A, Wada H.
Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer.
Biol. Pharm. Bull.
2020
PubMed ID: 32115500
DOI: 10.1248/bpb.b19-00702
|
|
13246
Bilguun EO, Kaira K, Kawabata-Iwakawa R, Rokudai S, Shimizu K, Yokobori T, Oyama T, Shirabe K, Nishiyama M.
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
BMC Cancer
2020
PubMed ID: 32993587
DOI: 10.1186/s12885-020-07448-2
|
|
13773
Saigusa D, Motoike IN, Saito S, Zorzi M, Aoki Y, Kitamura H, Suzuki M, Katsuoka F, Ishii H, Kinoshita K, Motohashi H, Yamamoto M.
Impacts of NRF2 activation in non-small-cell lung cancer cell lines on extracellular metabolites
Cancer Sci
2020
111(2):667-678
PubMed ID: 31828882
DOI: 10.1111/cas.14278
|
|
13429
Erkhem-Ochir Bilguunm, Kyoichi Kaira, Reika Kawabata-Iwakawa, Susumu Rokudai, Kimihiro Shimizu, Takehiko Yokobori, Tetsunari Oyama, Ken Shirabe, Masahiko Nishiyama
Syntaxin binding protein 4 as a novel therapeutic target and an effective biomarker for better treatment selection in lung squamous cell carcinoma: A theranostic study
BMC Cancer
2020
DOI: 10.21203/rs.3.rs-39783/v1
|
|
14834
Saito R, Miki Y, Abe T, Miyauchi E, Abe J, Nanamiya R, Inoue C, Sato I, Sasano H.
11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma
Br J Cancer
2020
123(1):61-71
PubMed ID: 32336752
DOI: 10.1038/s41416-020-0837-3
|
|
11379
Omoto K, Matsuda R, Nakai Y, Tatsumi Y, Nakazawa T, Tanaka Y, Shida Y, Murakami T, Nishimura F, Nakagawa I, Motoyama Y, Nakamura M, Fujimoto K, Hiroyuki N.
Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.
Photodiagnosis Photodyn Ther
2019
PubMed ID: 30639584
DOI: 10.1016/j.pdpdt.2019.01.009
|
|
11496
Miyake N, Chikumi H, Yamaguchi K, Takata M, Takata M, Okada K, Kitaura T, Nakamoto M, Yamasaki A.
Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines with Wild Type EGFR and Use of KRAS as a Possible Biomarker for Treatment Responsiveness.
Yonago Acta Med
2019
PubMed ID: 30962749
DOI: 10.33160/yam.2019.03.012
|
|
11816
Maruhashi R, Eguchi H, Akizuki R, Hamada S, Furuta T, Matsunaga T, Endo S, Ichihara K, Ikari A.
Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells.
Sci Rep
2019
PubMed ID: 31551535
DOI: 10.1038/s41598-019-50276-z
|
|
14814
Hamanaka N, Nakanishi Y, Mizuno T, Horiguchi-Takei K, Akiyama N, Tanimura H, Hasegawa M, Satoh Y, Tachibana Y, Fujii T, Sakata K, Ogasawara K, Ebiike H, Koyano H, Sato H, Ishii N, Mio T.
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification
Cancer Res
2019
79(22):5734-5745
PubMed ID: 31391186
DOI: 10.1158/0008-5472.CAN-18-3376
|
|
10748
Matsumoto T, Nagashio R, Ryuge S, Igawa S, Kobayashi M, Fukuda E, Goshima N, Ichinoe M, Jiang SX, Satoh Y, Masuda N, Murakumo Y, Saegusa M, Sato Y.
Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.
Pathol. Int.
2018
68:232-240
PubMed ID: 29431238
DOI: 10.1111/pin.12646
|
|
10842
Yanagita K, Nagashio R, Jiang SX, Kuchitsu Y, Hachimura K, Ichinoe M, Igawa S, Fukuda E, Goshima N, Satoh Y, Murakumo Y, Saegusa M, Sato Y.
Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer.
Am. J. Pathol.
2018
188:1328-1333
PubMed ID: 29751934
DOI: 10.1016/j.ajpath.2018.03.007
|
|
11149
Shimizu K, Okita R, Saisho S, Maeda AI, Nojima Y, Nakata M.
Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer.
Anticancer Res.
2018
38(8):4637-4644
PubMed ID: 30061230
DOI: 10.21873/anticanres.12768
|
|
14822
Hayashi T, Desmeules P, Smith RS, Drilon A, Somwar R, Ladanyi M.
RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition
Clin Cancer Res
2018
24(6):1436-1447
PubMed ID: 29127119
DOI: 10.1158/1078-0432.CCR-17-2343
|
|
7006
Iida K, Sakai R, Yokoyama S, Kobayashi N, Togo S, Yoshikawa HY, Rawangkan A, Namiki K, Suganuma M.
Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL.
Sci Rep
2017
7:17770
PubMed ID: 29259259
DOI: 10.1038/s41598-017-18120-4
|
|
9953
Akizuki R, Shimobaba S, Matsunaga T, Endo S, Ikari A.
Claudin-5, -7, and -18 suppress proliferation mediated by inhibition of phosphorylation of Akt in human lung squamous cell carcinoma.
Biochim. Biophys. Acta
2017
1864:293-302
PubMed ID: 27884700
DOI: 10.1016/j.bbamcr.2016.11.018
|
|
14238
Ozono K, Ohishi Y, Onishi H, Nakamura K, Motoshita J, Kato M, Nakanishi R, Nakamura M, Oda Y.
Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma
Lab Invest
2017
97(11):1332-1342
PubMed ID: 28604655
DOI: 10.1038/labinvest.2017.45
|
|
14683
Ono C, Fukuhara T, Motooka D, Nakamura S, Okuzaki D, Yamamoto S, Tamura T, Mori H, Sato A, Uemura K, Fauzyah Y, Kurihara T, Suda T, Nishio A, Hmwe SS, Okamoto T, Tatsumi T, Takehara T, Chayama K, Wakita T, Koike K, Matsuura Y.
Characterization of miR-122-independent propagation of HCV
PLoS Pathog
2017
13(5):e1006374
PubMed ID: 28494029
DOI: 10.1371/journal.ppat.1006374
|
|
14717
Kuji S, Watanabe R, Sato Y, Iwata T, Hirashima Y, Takekuma M, Ito I, Abe M, Nagashio R, Omae K, Aoki D, Kameya T.
A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases
Gynecol Oncol
2017
144(2):384-390.
PubMed ID: 27908529
DOI: 10.1016/j.ygyno.2016.11.020
|
|
9581
Shimobaba S, Taga S, Akizuki R, Hichino A, Endo S, Matsunaga T, Watanabe R, Yamaguchi M, Yamazaki Y, Sugatani J, Ikari A.
Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
Biochim. Biophys. Acta
2016
1863:1170-8
PubMed ID: 26919807
DOI: 10.1016/j.bbamcr.2016.02.015
|
|
9887
Ye X, Zhou Q, Matsumoto Y, Moriyama M, Kageyama S, Komatsu M, Satoh S, Tsuchida M, Saijo Y.
Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
Anticancer Res.
2016
36:6021-6029
PubMed ID: 27793929
DOI: 10.21873/anticanres.11191
|
|
12612
Yonesaka K, Hirotani K, Kawakami H, Takeda M, Kaneda H, Sakai K, Okamoto I, Nishio K, Jänne PA, Nakagawa K.
Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib
Oncogene
2016
35(7):878-86
PubMed ID: 25961915
DOI: 10.1038/onc.2015.142
|
|
14314
Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, Lundqvist A, Kiessling R, Seliger B, Nakata M.
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
PLoS One
2015
10(10):e0139809
PubMed ID: 26439264
DOI: 10.1371/journal.pone.0139809
|
|
15182
Saito K, Kobayashi M, Nagashio R, Ryuge S, Katono K, Nakashima H, Tsuchiya B, Jiang SX, Saegusa M, Satoh Y, Masuda N, Sato Y.
S100A16 is a Prognostic Marker for Lung Adenocarcinomas
Asian Pac J Cancer Prev
2015
16(16):7039-44
PubMed ID: 26514487
DOI: 10.7314/apjcp.2015.16.16.7039
|
|
15436
Kusakabe K, Ide N, Daigo Y, Itoh T, Yamamoto T, Kojima E, Mitsuoka Y, Tadano G, Tagashira S, Higashino K, Okano Y, Sato Y, Inoue M, Iguchi M, Kanazawa T, Ishioka Y, Dohi K, Kido Y, Sakamoto S, Ando S, Maeda M, Higaki M, Yoshizawa H, Murai H, Nakamura Y.
A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity
Bioorg Med Chem
2015
23(9):2247-60
PubMed ID: 25801152
DOI: 10.1016/j.bmc.2015.02.042
|
|
15907
Chen Z, Ye X, Tang N, Shen S, Li Z, Niu X, Lu S, Xu L.
The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer
Br J Pharmacol
2014
171(13):3196-211
PubMed ID: 24571482
DOI: 10.1111/bph.12661
|
|
18077
Shiho Sakuma, Eiko Otake, Kan Torii, Motoki Nakamura, Akira Maeda, Ryoto Tujii, Haruo Akashi, Hiromi Ohi, Shigenobu Yano, Akimichi Morita
Photodynamic therapy with glycoconjugated chlorin photosensitizer
Journal of Porphyrins and Phthalocyanines
2013
17:331-342
DOI: 10.1142/S1088424613500065
|
|
18278
Yamaguchi H, Kidachi Y, Kamiie K, Noshita T, Umetsu H, Fuke Y, Ryoyama K.
Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies
Biochem Pharmacol
2013
86(4):458-68
PubMed ID: 23791871
DOI: 10.1016/j.bcp.2013.06.008
|
|
13951
Oshita H, Nishino R, Takano A, Fujitomo T, Aragaki M, Kato T, Akiyama H, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y.
RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer
Mol Cancer Res
2013
11(8):937-51
PubMed ID: 23686708
DOI: 10.1158/1541-7786.MCR-12-0685-T
|
|
7627
Ohue Y, Eikawa S, Okazaki N, Mizote Y, Isobe M, Uenaka A, Fukuda M, Old LJ, Oka M, Nakayama E.
Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
Int. J. Cancer
2012
131:E649-58
PubMed ID: 22109656
DOI: 10.1002/ijc.27359
|
|
19226
Fukuhara T, Kambara H, Shiokawa M, Ono C, Katoh H, Morita E, Okuzaki D, Maehara Y, Koike K, Matsuura Y.
Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus
J Virol
2012
86(15):7918-33
PubMed ID: 22593164
DOI: 10.1128/JVI.00567-12
|
|
9094
Yumiko Shimura, Junya Suzuki, Miho Muraoka, Maria Carmelita Zulueta Kasuya, Koji Matsuoka, Kenichi Hatanaka
Large Scale Biosynthesis of Ganglioside Analogues by RERF-LC-AI Cells Cultured in HYPERFlask
Prep Biochem Biotechnol
2012
42 (4), 378-92
PubMed ID: 22708814
DOI: 10.1080/10826068.2011.627971
|
|
12718
Ikari A, Sato T, Watanabe R, Yamazaki Y, Sugatani J.
Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells
Biochim Biophys Acta
2012
1823(6):1110-8
PubMed ID: 22546605
DOI: 10.1016/j.bbamcr.2012.04.005
|
|
13664
Ohgidani M, Ichihara H, Goto K, Matsumoto Y, Ueoka R.
Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo
Biol Pharm Bull
2012
35(6):984-7
PubMed ID: 22687544
DOI: 10.1248/bpb.35.984
|
|
14287
Kobayashi M, Matsumoto T, Ryuge S, Yanagita K, Nagashio R, Kawakami Y, Goshima N, Jiang SX, Saegusa M, Iyoda A, Satoh Y, Masuda N, Sato Y.
CAXII Is a sero-diagnostic marker for lung cancer
PLoS One
2012
7(3):e33952
PubMed ID: 22439015
DOI: 10.1371/journal.pone.0033952
|
|
14406
Miyake N, Chikumi H, Takata M, Nakamoto M, Igishi T, Shimizu E.
Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells
Oncol Rep
2012
28(3):848-54
PubMed ID: 22710790
DOI: 10.3892/or.2012.1855
|
|
17472
Ashinuma H, Takiguchi Y, Kitazono S, Kitazono-Saitoh M, Kitamura A, Chiba T, Tada Y, Kurosu K, Sakaida E, Sekine I, Tanabe N, Iwama A, Yokosuka O, Tatsumi K.
Antiproliferative action of metformin in human lung cancer cell lines
Oncol Rep
2012
28(1):8-14
PubMed ID: 22576795
DOI: 10.3892/or.2012.1763
|
|
16552
Tasaki M, Shimada K, Kimura H, Tsujikawa K, Konishi N.
ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer
Br J Cancer
2011
104(4):700-6
PubMed ID: 21285982
DOI: 10.1038/sj.bjc.6606012
|
|
16553
Hayashi S, Kumai T, Matsuda Y, Aoki N, Sato K, Kimura S, Kitada M, Tateno M, Celis E, Kobayashi H.
Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
J Transl Med
2011
9:191
PubMed ID: 22053850
DOI: 10.1186/1479-5876-9-191
|
|
5870
Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K, Kataoka H.
Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.
Int J Cancer.
2010
126(7):1611-20
PubMed ID: 19711349
DOI: 10.1002/ijc.24865
|
|
18295
Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, Kikuchi N, Satoh H, Sakamoto T, Hizawa N, Itoh K, Yamamoto M.
Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer
Clin Cancer Res
2009
15(10):3423-32
PubMed ID: 19417020
DOI: 10.1158/1078-0432.CCR-08-2822
|
|
5877
Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S.
FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.
Biol Pharm Bull
2009
32(7):1148-54
PubMed ID: 19571376
DOI: 10.1248/bpb.32.1148
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
18307
Moriya S, Takiguchi M, Seki N.
Expression of the WT1 gene -KTS domain isoforms suppresses the invasive ability of human lung squamous cell carcinoma cells
Int J Oncol
2008
32(2):349-56
PubMed ID: 18202757
|
|
18890
Nagashio R, Sato Y, Jiang SX, Ryuge S, Kodera Y, Maeda T, Nakajima T.
Detection of tumor-specific autoantibodies in sera of patients with lung cancer
Lung Cancer
2008
62(3):364-73
PubMed ID: 18485524
DOI: 10.1016/j.lungcan.2008.03.026
|
|
5888
Kuwabara Y, Yamada T, Yamazaki K, Du WL, Banno K, Aoki D, Sakamoto M.
Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis.
Cancer Sci
2008
99(10):1933-9
PubMed ID: 19016752
DOI: 10.1111/j.1349-7006.2008.00946.x
|
|
15561
Kouta Funamoto, Yuji Komizu, Hideaki Ichihara, Osamu Tanoue, Koichi Goto, Ryuichi Ueoka
Antitumor and Immunostimulatory Effects of Residual Powder from Barley-Shochu Distillation Remnants
Journal of Health Science
2008
54:287-293
DOI: 10.1248/jhs.54.287
|
|
19222
Noro R, Gemma A, Miyanaga A, Kosaihira S, Minegishi Y, Nara M, Kokubo Y, Seike M, Kataoka K, Matsuda K, Okano T, Yoshimura A, Kudoh S.
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors
Int J Oncol
2007
31(5):1157-63
PubMed ID: 17912443
|
|
6291
Asaka-Amano Y, Takiguchi Y, Yatomi M, Kurosu K, Kasahara Y, Tanabe N, Tatsumi K, Kuriyama T.
Effect of treatment schedule on the interaction of Cisplatin and radiation in human lung cancer cells.
Radiat Res
2007
167(6):637-44
PubMed ID: 17523845
DOI: 10.1667/RR0739.1
|
|
17469
Takiguchi Y, Miyamoto T, Nagao K, Kuriyama T.
Assessment of the homogeneous efficacy of carbon ions in the spread-out Bragg peak for human lung cancer cell lines
Radiat Med
2007
25(6):272-7
PubMed ID: 17634880
DOI: 10.1007/s11604-007-0134-6
|
|
3335
Yoshino K, Iimura E, Saijo K, Iwase S, Fukami K, Ohno T, Obata Y, Nakamura Y.
Essential role for gene profiling analysis in the authentication of human cell lines.
Hum Cell
2006
19(1):43-8
PubMed ID: 16643607
DOI: 10.1111/j.1749-0774.2005.00007.x
|
|
3061
Nagai, Yoshiaki, Miyazawa, Hitoshi, Tanaka, Tomoaki, Udagawa, Kiyoshi, Kato, Motoyasu, Fukuyama, Shunichiro, Yokote, Akemi, Kobayashi, Kunihiko, Kanazawa, Minoru, Hagiwara, Koichi, Hagiwara K
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.
Cancer Res
2005
65:7276-82
PubMed ID: 16105816
DOI: 10.1158/0008-5472.CAN-05-0331
|
|
16489
Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S.
Proteomic signatures for histological types of lung cancer
Proteomics
2005
5(11):2939-48
PubMed ID: 15996008
DOI: 10.1002/pmic.200401166
|
|
3107
Hashimoto, Kiyoshi, Araki, Kunio, Osaki, Mitsuhiko, Nakamura, Hiroshige, Tomita, Katsuyuki, Shimizu, Eiji, Ito, Hisao
MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications.
Pathobiology
2004
71:193-200
PubMed ID: 15263808
DOI: 10.1159/000078673
|
|
3338
Seike, Masahiro, Kondo, Tadashi, Fujii, Kazuyasu, Yamada, Tesshi, Gemma, Akihiko, Kudoh, Shoji, Hirohashi, Setsuo
Proteomic signature of human cancer cells.
Proteomics
2004
4:2776-88
PubMed ID: 15352251
DOI: 10.1002/pmic.200300795
|
|
13883
Kobayashi H, Takemura Y, Hayashi T, Ujiiye T, Kawase M, Niino Y, Miyachi H, Ohshima T, Hotta T.
Expression level of MDR1 message in peripheral blood leukocytes from healthy adults: a competitive nucleic acid sequence-based amplification assay for its determination
Clin Chem Lab Med
2004
42(10):1098-101
PubMed ID: 15552266
DOI: 10.1515/CCLM.2004.226
|
|
16491
Nakanishi H, Suda T, Katoh M, Watanabe A, Igishi T, Kodani M, Matsumoto S, Nakamoto M, Shigeoka Y, Okabe T, Oshimura M, Shimizu E.
Loss of imprinting of PEG1/MEST in lung cancer cell lines
Oncol Rep
2004
12(6):1273-8
PubMed ID: 15547750
|
|
19272
Omori S, Takiguchi Y, Suda A, Sugimoto T, Miyazawa H, Takiguchi Y, Tanabe N, Tatsumi K, Kimura H, Pardington PE, Chen F, Chen DJ, Kuriyama T.
Suppression of a DNA double-strand break repair gene, Ku70, increases radio- and chemosensitivity in a human lung carcinoma cell line
DNA Repair (Amst)
2002
1(4):299-310
PubMed ID: 12509248
DOI: 10.1016/s1568-7864(02)00006-x
|
|
5955
Fujiwara H, Kikkawa Y, Sanzen N, Sekiguchi K.
Purification and characterization of human laminin-8. Laminin-8 stimulates cell adhesion and migration through alpha3beta1 and alpha6beta1 integrins.
J Biol Chem
2001
276(20):17550-8
PubMed ID: 11278628
DOI: 10.1074/jbc.M010155200
|
|
2427
Ando S, Nojima K, Ishihara H, Suzuki M, Ando M, Majima H, Ando K, Kuriyama T
Induction by carbon-ion irradiation of the expression of vascular endothelial growth factor in lung carcinoma cells.
Int J Radiat Biol
2000
76:1121-7
PubMed ID: 10947125
DOI: 10.1080/09553000050111596
|
|
9026
H Uchida, N Kiyokawa, T Taguchi, H Horie, J Fujimoto, T Takeda
Shiga Toxins Induce Apoptosis in Pulmonary Epithelium-Derived Cells
Infect Dis
1999
180 (6), 1902-11
PubMed ID: 10558947
DOI: 10.1086/315131
|
|
18562
Kikkawa Y, Sanzen N, Sekiguchi K.
Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. laminin-10/11 mediates cell adhesion through integrin alpha3 beta1
J Biol Chem
1998
273(25):15854-9.
PubMed ID: 9624186
DOI: 10.1074/jbc.273.25.15854
|
|
1392
Ando S, Nojima K, Majima H, Ishihara H, Suzuki M, Furusawa Y, Yamaguchi H, Koike S, Ando K, Yamauchi M, Kuriyama T.
Evidence for mRNA expression of vascular endothelial growth factor by X-ray irradiation in a lung squamous carcinoma cell line
Cancer Lett
1998
132(1-2):75-80
PubMed ID: 10397456
DOI: 10.1016/s0304-3835(98)00160-8
|
|
17998
Ohata H, Seito N, Yoshida K, Momose K.
Lysophosphatidic acid sensitizes mechanical stress-induced Ca2+ mobilization in cultured human lung epithelial cells
Life Sci
1996
58(1):29-36
PubMed ID: 8628108
DOI: 10.1016/0024-3205(95)02252-x
|
|
6249
Teraoka S1 Kyoizumi S, Suzuki T, Yamakido M, Akiyama M.
Growth suppressive efficacy of human lak cells against human lung-cancer implanted into scid mice.
Int J Oncol
1995
6(6):1271-7
PubMed ID: 21556669
DOI: 10.3892/ijo.6.6.1271
|
|
1901
Liu SQ, Shiba R, Kim BS, Saijo K, Ohno T.
Long-term serum/plasma-free culture of human cytotoxic T lymphocytes i
Cancer Immunol Immunother
1994
39(5):279-85
PubMed ID: 7987858
DOI: 10.1007/BF01519979
|
|
1902
Shu Qin Liu, Kaoru Saijo, Makoto Kodama, Tadao Ohno
Intelligent matrices for tumor-specific cytotoxic T lymphocytes
Materials Science and Engineering: C
1994
2:61-65
DOI: 10.1016/0928-4931(94)90030-2
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
